In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Authorized Generics: Band-Aid or Strategy?

Executive Summary

In the past two years, some Big Pharma companies have revitalized their long-dormant generics activities and launched generic copies of their own drugs. They're doing this to capture business they would otherwise lose completely and to tie up generics competitors in court. While similar strategies failed in the past, a number of changes may make it more feasible. Innovators are behaving more rationally about pricing. And they are going after the most lucrative part of the generics business.
Advertisement

Related Content

Generic Plavix: As Bristol Swoons, Broad Implications
Teva/Ivax: Generics' Answer to Big Pharma
Novartis/Hexal: Generic Consolidation, and More
Savoring Sabex: Sandoz' Play in Injectable Generics
In Generics, An Update on Reform
Purdue Battles Generics, Early
Reforming--Balancing, Ruining, Whatever--Hatch Waxman
Pfizer v. Reddy: Drug Patents Under Fire
Teva's Growth Momentum
Generic Update: Brand-Name Companies Vs. Independents

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel